Form 8-K - Current report:
SEC Accession No. 0001104659-24-089000
Filing Date
2024-08-13
Accepted
2024-08-13 16:32:52
Documents
15
Period of Report
2024-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421451d1_8k.htm   iXBRL 8-K 30307
2 EXHIBIT 10.1 tm2421451d1_ex10-1.htm EX-10.1 126711
  Complete submission text file 0001104659-24-089000.txt   393210

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20240813.xsd EX-101.SCH 3742
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20240813_def.xml EX-101.DEF 26569
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20240813_lab.xml EX-101.LAB 37178
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20240813_pre.xml EX-101.PRE 25184
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2421451d1_8k_htm.xml XML 4302
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 241202227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)